HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
10.1 USD
-0.01 (-0.1%)
10.4 USD
+0.3 (+2.97%)
Overall HLN gets a fundamental rating of 5 out of 10. We evaluated HLN against 192 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are quite some concerns on its financial health. HLN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
HLN had positive earnings in the past year.
HLN had a positive operating cash flow in the past year.
HLN had positive earnings in each of the past 5 years.
HLN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 4.20%, HLN belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
The Return On Equity of HLN (8.92%) is better than 84.38% of its industry peers.
With an excellent Return On Invested Capital value of 6.11%, HLN belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
HLN's Profit Margin of 12.84% is amongst the best of the industry. HLN outperforms 85.42% of its industry peers.
In the last couple of years the Profit Margin of HLN has grown nicely.
Looking at the Operating Margin, with a value of 21.31%, HLN belongs to the top of the industry, outperforming 89.06% of the companies in the same industry.
HLN's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 60.75%, HLN is doing good in the industry, outperforming 70.31% of the companies in the same industry.
In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
Compared to 1 year ago, HLN has less shares outstanding
Compared to 5 years ago, HLN has less shares outstanding
Compared to 1 year ago, HLN has a worse debt to assets ratio.
2.2 Solvency
HLN has an Altman-Z score of 2.31. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN's Altman-Z score of 2.31 is in line compared to the rest of the industry. HLN outperforms 59.90% of its industry peers.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLN (5.11) is better than 82.29% of its industry peers.
HLN has a Debt/Equity ratio of 0.53. This is a neutral value indicating HLN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, HLN is doing worse than 64.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.31 |
ROIC/WACC0.71
WACC8.63%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
HLN's Current ratio of 0.98 is on the low side compared to the rest of the industry. HLN is outperformed by 84.90% of its industry peers.
A Quick Ratio of 0.78 indicates that HLN may have some problems paying its short term obligations.
With a Quick ratio value of 0.78, HLN is not doing good in the industry: 83.85% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
HLN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
The Revenue has decreased by -0.61% in the past year.
HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
HLN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.76% on average per year.
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.20 indicates a rather expensive valuation of HLN.
80.73% of the companies in the same industry are more expensive than HLN, based on the Price/Earnings ratio.
HLN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
Based on the Price/Forward Earnings ratio of 17.38, the valuation of HLN can be described as rather expensive.
Based on the Price/Forward Earnings ratio, HLN is valued a bit cheaper than the industry average as 78.65% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, HLN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.2 | ||
| Fwd PE | 17.38 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaper than 81.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HLN is valued cheaper than 85.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.8 | ||
| EV/EBITDA | 15.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.55
PEG (5Y)1.15
EPS Next 2Y8%
EPS Next 3Y8.66%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.84%, HLN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.45, HLN pays a better dividend. On top of this HLN pays more dividend than 92.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, HLN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
5.2 History
HLN has paid a dividend for at least 10 years, which is a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
HLN pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y8%
EPS Next 3Y8.66%
10.1
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap44.97B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price TargetN/A
Short Float %0.29%
Short Ratio1.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.84% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.4%
PT rev (3m)-3.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.27%
EPS NY rev (3m)0.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.2 | ||
| Fwd PE | 17.38 | ||
| P/S | 2.97 | ||
| P/FCF | 16.8 | ||
| P/OCF | 14.47 | ||
| P/B | 2.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.15 |
EPS(TTM)0.5
EY4.95%
EPS(NY)0.58
Fwd EY5.75%
FCF(TTM)0.6
FCFY5.95%
OCF(TTM)0.7
OCFY6.91%
SpS3.41
BVpS4.9
TBVpS-3.05
PEG (NY)3.55
PEG (5Y)1.15
Graham Number7.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.31 |
F-Score6
WACC8.63%
ROIC/WACC0.71
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.69%
EBIT Next 3Y8.39%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.2 and the Price/Book (PB) ratio is 2.06.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 3 / 10.